Continuation Vehicles: Worth the Wait?

September 15, 2026 | Amy Miller, Associate Director of Private Equity

Over the past decade, continuation vehicles (“CV”) have become one of the fastest-growing trends in private equity. Private equity funds typically have a fixed lifespan, often around ten years. During that period, the fund buys companies, works to improve them, and ultimately sells them to generate returns for investors. However, not every company reaches its full potential within that timeframe. In fact, there has been much ado about Zombie portfolio companies as aging assets face limited and increasingly challenging exit opportunities.

A CV allows a private equity manager, or general partner (“GP”) to continue owning a company beyond the life of the original fund. The GP transfers the company into a newly created investment vehicle and raises new capital from investors to purchase interests from those who opt for liquidity. Existing investors can choose to sell and receive cash or remain invested in the company through the new structure.

Once considered a niche solution, CVs have become a mainstream feature of the private equity market. Supporters argue that they allow GPs to maximize value by giving strong companies more time to grow. Critics counter that they introduce conflicts of interest and make it harder to assess whether investors are receiving fair value. As use of these structures continues to expand, investors should understand both the benefits and the risks before embracing them as a permanent solution to today’s liquidity challenges.

Read > Continuation Vehicles: Worth the Wait?

Amy Miller
Associate Director of Private Equity

Get to Know Amy

The opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.

Related Content

Combination stacked column and line chart showing U.S. Buyout (private equity) Net Asset Value holding periods, 2011 to 2025. Column categories include holding periods

08.31.2026

Zombie, Inc.

Private equity has always had a few portfolio companies that refused to leave the party. Today, however, the industry appears…

07.24.2026

2026 Halftime Market Insights

This video is a recording of a live webinar held July 23 by Marquette’s research team analyzing the first half…

07.22.2026

Under the Radar for the Second Half

The usual midyear version of these letters has touched on year-to-date performance as well as the most influential macroeconomic and…

Column chart showing share of private equity exit value by type in billions across acquisition, buyout, public listing, and continuation vehicles annually, 2016 to 2026 YTD. Since 2019, continuation vehicles have grown in share, with 2025 at their highest level of $98b. For full dataset, please contact marquettemarketing@marquetteassociates.com.

07.06.2026

To CV or Not to CV?

Since traditional exit routes have remained constrained in recent years due to higher interest rates, valuation gaps, and a subdued…

06.25.2026

Commodities: An Overview of the Asset Class

Commodities represent a unique asset class within global financial markets. Like equities and bonds, commodity prices are influenced by the…

Two-line chart showing median and average time in years for global unicorns to exit, 2016 to 2025. The 2025 data point (9.2 years median, 9.7 years average) is the highest point charted. In 2016, the median was 6.1 years and average was 6.0. For full dataset, please contact marquettemarketing@marquetteassociates.com.

06.22.2026

The VC Convergence Era

When Benchmark, one of Silicon Valley’s most renowned early-stage venture capital firms, closed $2 billion across two new funds this…

More articles

Subscribe to Research Email Alerts

Research Email Alert Subscription

Research alerts keep you updated on our latest research publications. Simply enter your contact information, choose the research alerts you would like to receive and click Subscribe. Alerts will be sent as research is published.

We respect your privacy. We will never share or sell your information.

Thank You

We appreciate your interest in Marquette Associates.

If you have questions or need further information, please contact us directly and we will respond to your inquiry within 24 hours.

Contact Us >